Targets in small cell lung cancer

Biochemical Pharmacology

Volumn 87, Issue 2, 2014, Pages 211-219

  Teicher, Beverly A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CD24; CD56; Myc; SCLC; Small cell lung cancer

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ADENOSINE TRIPHOSPHATE; BOMBESIN RECEPTOR; BRADYKININ RECEPTOR; CD151 ANTIGEN; CD24 ANTIGEN; CD56 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; FIBROBLAST GROWTH FACTOR RECEPTOR; GLUCOSE TRANSPORTER 1; MYC PROTEIN; NERVE CELL ADHESION MOLECULE; OCTAMER TRANSCRIPTION FACTOR 4; OXYTOCIN; PROTEIN BCL 2; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR SOX11; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX4; VASOPRESSIN;

CELL METABOLISM; CELL SURFACE; GENE OVEREXPRESSION; GENE TARGETING; GLYCOLYSIS; HUMAN; LUNG SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SURVIVAL FACTOR;

CD24; CD56; MYC; SCLC; SMALL CELL LUNG CANCER;

ANIMALS; CELL MEMBRANE; GENE TARGETING; HUMANS; LUNG NEOPLASMS; SMALL CELL LUNG CARCINOMA; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84892369037     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2013.09.014     Document Type: Note

References (80)

1. A. Paumier, and C. Le Pechoux Radiotherapy in small cell lung cancer: where should it go Lung Cancer 69 2010 133 140
2. E. Rodriguez, and R.C. Lilenbaum Small cell lung cancer: past, present and future Curr Oncol Rep 12 2010 327 334
3. S.P. D'Angelo, and M.C. Pietanza The molecular pathogenesis of small cell lung cancer Cancer Biol Ther 10 2010 1 10
4. B.E. Johnson, E. Russell, A.M. Simmons, R. Phelps, S.M. Steinberg, and D.C. Ihde et al. MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer J Cell Biochem Suppl 24 1996 210 217
5. G. Kristiansen, M. Sammar, and P. Altevogt Tumor biological aspects of CD24, a mucin-like adhesion molecule J Mol Histol 35 2004 255 262 (Pubitemid 40585311)
6. E. Weber, D. Schmitter, H. Resch, J.A. Zarn, R. Waibel, and M. Mabry et al. Radiation studies on B cell differentiation marker CD24/SCLC cluster-4 antigen expressing and non-expressing lung cancer cell lines and mouse fibroblasts Int J Radiat Biol 68 1995 205 213
7. C.T. Mierke, N. Bretz, and P. Altevogt Contractile forces contribute to increased glycosylphosphatidylinositiol-anchored receptor CD24-facilitated cancer cell invasion J Biol Chem 286 2011 3458 3471
8. S. Thomas, M.A. Harding, S.C. Smith, J.B. Overdevest, M.D. Nitz, and H.F. Frierson et al. CD24 is an effector of HIF-1-driven primary tumor growth and metastasis Cancer Res 72 2012 5600 5612
9. J. Wan, H. Chai, Z. Yu, W. Ge, N. Kang, and W. Xia et al. HIF-1α effects on angiogenic potential in human small cell lung carcinoma J Exp Clin Cancer Res 30 2011 77
10. U. Zangemeister-Wittke, H.P. Lehmann, R. Waibel, E.J. Wawrzynczak, and R.A. Stahel Action of a CD24-specific degylcosylated ricin-A chain immunotoxin in conventional and novel models of small cell lung cancer xenograft Int J Cancer 53 1993 521 528 (Pubitemid 23047904)
11. A.V. Salnikov, N.P. Bretz, C. Perne, J. Hazin, S. Keller, and M. Fogel et al. Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas Br J Cancer 108 2013 1449 1459
12. B.A. Froesch, R.A. Stahel, and U. Zangemeister-Wittke preparation and functional evaluation of new doxorubicin immunoconjugates containing an acid-sensitive linker on small cell lung cancer cells Cancer Immunol Immunother 42 1996 5 62
13. O.J. McGinn, G. Marinov, S. Sawan, and P.L. Stern CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofetal glycoprotein J Cell Sci 125 2012 5467 5478
14. J.S.N. Peguero, L.H. Camacho, B. Kemp, and L.T. Campos Chemokine expression in tumor-to-tumor metastasis Oncol Lett 1 2010 449 452
15. B.A. Teicher, and S.P. Fricjer CXCL12 (SDF-1)/CXCR4 pathway in cancer Clin Cancer Res 16 2010 2927 2931
16. M. Burger, A. Glodek, T. Hartmann, A. Schmitt-Graff, L.E. Silberstein, and N. Fujii et al. Functional expression of CXCR4 (CD184) on small cell lung cancer cells mediates migration, integrin activation and adhesion to stromal cells Oncogene 22 2003 8093 8101 (Pubitemid 37487300)
17. E. Martinez-Garcia, M. Irigoyen, O. Gonzalez-Moreno, L. Corrales, A. Teijeira, and E. Salvo et al. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment Toxicol Sci 116 2010 467 476
18. T.N. Hartmann, J.A. Burger, A. Glodek, N. Fujii, and M. Burger CXCR4 chemokine and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells Oncogene 24 2005 4462 4471 (Pubitemid 40961769)
19. 68Ga-labeled highly specific targeted contrast agent J Nucl Med 52 2011 1803 1810
20. Y. Otani, T. Kijima, S. Kohmo, S. Oishi, T. Minami, and I. Nagatomo et al. Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016 FEBS Lett 586 2012 3639 3644
21. 14] bombesin(6-14) Clin Cancer Res 8 2002 1139 1146 (Pubitemid 35177367)
22. X. Hou, L. Wei, A. Harada, and K. Tatamoto Activation of bombesin receptor subtype-3 stimulates adhesion of lung cancer cells Lung Cancer 54 2006 143 148 (Pubitemid 44764926)
23. Z. Fathi, J.W. Way, M.H. Corjay, J. Viallet, E.A. Sausville, and J.F. Battey Bombesin receptor structure and expression in human lung carcinoma cell lines J Cell Biochem Suppl 24 1996 237 246
24. D.C. Chan, L. Gera, J.M. Stewart, B. Helfrich, T.L. Zhao, and W.Y. Feng et al. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents Clin Cancer Res 8 2002 1280 1287 (Pubitemid 34517669)
25. J.M. Stewart, D.C. Chan, L. Stewart, V. Stimkeviciene, and B. Helfrich New lung cancer drugs from bradykinin antagonists Chest 125 2004 148S (Pubitemid 38648359)
26. D. Bironaite, L. Gera, and J.M. Stewart Characterization of the B2 receptor and activity of bradykinin analogs in SHP-77 cell line cytosensor microphysiometer Chem Biol Interact 150 2004 283 293 (Pubitemid 39550979)
27. B.P. Keegan, V.A. Memoli, and W.G. North Targeting the neurophysin-related cell surface antigen on small cell lung cancer cells using a monoclonal antibody against the glycopeptide region (MAG-1) of provasopressin Mol Cancer Ther 1 2002 1153 1159
28. C. Pequeux, B.P. Keegan, M.T. Hagelstein, V. Geenen, J.J. Legros, and W.G. North Oxytocin- and vasopressin-induced growth of human small cell lung cancer is mediated by the mitogen-activated protein kinase pathway Endocrine-Relat Cancer 11 2004 871 885 (Pubitemid 40065559)
29. C. Pequeux, C. Breton, M.T. Hagelstein, V. Geenen, and J.J. Legros Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung Lung Cancer 50 2005 177 188 (Pubitemid 41427893)
30. T. Piazza, E. Cha, I. Bonarzone, S. Canevari, A. Bolognesi, and L. Polito et al. Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody J Cell Sci 118 2005 1515 1525 (Pubitemid 40585131)
31. M.T. Wiiger, H.B. Gehrken, O. Fodstad, G.M. Maelandsmo, and Y. Andersson A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumor growth Cancer Immunol Immunother 59 2010 1665 1674
32. H.X. Wang, Q. Li, C. Sharma, K. Knoblich, and M.E. Hemler Tetraspanin protein contributions to cancer Biochem Soc Trans 39 2011 547 552
33. Y. Takeda, A.R. Kazarov, C.E. Butterfield, B.D. Hopkins, L.E. Benjamin, and A. Kaipainen et al. Deletion of tetraspanin CD151 results in decreased pathologic angiogensis in vivo and in vitro Blood 109 2007 1524 1532 (Pubitemid 46239585)
34. Y. Takeda, Q. Li, A.R. Kazarov, M. Epardaud, K. Elpek, and S.J. Turley Diminished metastasis in tetraspanin CD151-knockout mice Blood 118 2011 464 472
35. T. Funakoshi, I. Tachibana, Y. Hoshida, H. Kimura, Y. Takeda, and T. Kijima et al. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer Oncogene 22 2003 674 687 (Pubitemid 36269281)
36. K. Kontogianni, A.G. Nicholson, D. Butcher, and M.N. Sheppard CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopies with extensive crush artifact J Clin Pathol 58 2005 978 980 (Pubitemid 41265285)
37. P.J. Woll, K.N. Moore, S. Bhatia, F.V. Fossella, L.C. Chen, and M. O'Brien et al. Efficacy results from a phase I study of lorvotuzumab mertansine (IMGN901) in patients with CED56-positive solid tumors J Clin Oncol 29 2011 e13582
38. R.L. Zinn, E.F. Gardner, L. Marchionni, S.C. Murphy, I. Dobromilskaya, and C.L. Hann et al. ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer Mol Cancer Ther 12 2013 1131 1139
39. M.V. Dieci, M. Arnedos, F. Andre, and J.C. Soria Fibroblast growth factor receptor inhibitors as a cancer treatment: from a biologic rationale to medical perspectives Cancer Disc 3 2013 264 279
40. T.C. Harding, L. Long, S. Palencia, H. Zhang, A. Sadra, and K. Hestir et al. Blockade of nonhormonal fibroblast growth factors by FP-1039 inhibits growth of multiple types of cancer Sci Trans Med 5 2013 178ra39
41. M.L. Sos, F. Dietlein, M. Peifer, J. Schottle, H. Balke-Want, and C. Muller et al. A framework for identification of actionable cancer genome dependencies in small cell lung cancer Proc Natl Acad Sci USA 109 2012 17034 17039
42. N. Shivapurkar, J. Reddy, H. Matta, U.G. Sathyanarayana, C.X. Huang, and S. Toyooka et al. Loss expression of death-inducing signaling complex (DISC) compoents in lung cancer cell lines and the influence of MYC amplification Oncogene 21 2002 8510 8514 (Pubitemid 36054892)
43. J. Voortman, H.H. Lee, J.K. Killian, M. Suuriniemi, Y. Wang, and M. Lucchi et al. Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors Proc Natl Acad Sci USA 107 2010 13040 13045
44. Z. Nie, G. Hu, G. Wei, K. Cui, A. Yamane, and W. Resch et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells Cell 151 2012 68 79
45. C.Y. Lin, J. Loven, P.B. Rahl, R.M. Paranal, C.B. Burge, and J.E. Bradner et al. Transcriptional amplification in tumor cells with elevated c-Myc Cell 151 2012 56 67
46. M.R. Doe, J.M. Ascano, M. Kaur, and M.D. Cole Myc posttranscrptionally induces HIF1 protein and target gene expression in normal and cancer cells Cancer Res 72 2011 1 9
47. W.J. Wang, S.P. Wu, J.B. Liu, Y.S. Shi, X. Huang, and Q.B. Zhang et al. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells Cancer Res 73 2012 1219 1231
48. K.C. Sedoris, S.D. Thomas, C.R. Clarkson, D. Muench, A. Islam, and R. Singh et al. Genomic c-Myc quadruplex DNA selectively kills leukemia Mol Cancer Ther 11 2012 66 76
49. R.W. Schnepp, and J.M. Maris Targeting MYCN: a good BET for improving neuroblastoma therapy? Cancer Discov 3 2013 255 257
50. R.K. Prinjha, J. Witherington, and K. Lee Place your BETs: the therapeutic potential of bromodomains Trends Pharm Sci 33 2012 146 153
51. B. Melichar, A. Adenis, L. havel, A.C. Lockhart, J. Bennouna, and C. Schusterbauer et al. Phase (Ph) I/II study of investigational Aurora A kinase (AAK) inhibitor MLN8237 (alisertib): updated ph II resutls in patients (pts) with small cell lung cancer (SCLC), non-SCLC (NSCLC), breast cancer (BrC), head and neckj squamous cell carinoma (HNSCC), and gastroesophageal cancer (GE) J Clin Oncol 31 Suppl. 2013 abstr 605
52. J.A. Bonner, J.A. Sloan, K.M. Rowland, G.G. Klee, J.W. Kugler, and J.A. Mailliard et al. Significance of neuron-specific enolase levels before and during therapy for small cell lung cancer Clin Cancer Res 6 2000 597 601 (Pubitemid 30111484)
53. K.C. Sedoris, S.D. Thomas, and D.M. Miller Hypoxia induces differential translation of enolase/MBP-1 BMC Cancer 10 2010 157
54. R. Kanteti, V. Nallasura, S. Loganathan, M. Tretiakova, T. Kroll, and S. Krishnaswamy et al. PAX5 is expressed in small cell lung cancer and positively regulates c-Met transcription Lab Invest 89 2009 301 314
55. J. Song, M. Li, M. Tretiakova, R. Salgia, P. Cagle, and A.N. Husain Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung Arch Pathol Lab Med 134 2010 1702 1705
56. NCI-2012-01220. Tivantinib and topotecan hydrochloride in treating patients with advanced or metastatic solid tumors or recurrent small cell lung cancer.
57. X. Zhao, X. Sun, and X.L. Li Expression and clinical significance of STAT3, P-STAT3 and VEGF-c in small cell lung cancer Asian Pac J Cancer Prev 13 2012 2873 2877
58. L.A. Byers, J. Wang, M. Nilsson, J. Fujimoto, P. Saintigny, and J. Yordy et al. Proteomic profiling indentifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1 Cancer Discov 2 2012 798 811
59. R. Rosell, and L. Wannesson A genetic snapshot of small cell lung cancer Cancer Discov 2 2012 769 771
60. W. Fiskus, M. Pranpat, M. Balasis, B. Herger, R. Rao, and A. Chinnaiyan et al. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells Mol Cancer Ther 5 2006 3096 3104 (Pubitemid 46092051)
61. W. Fiskus, Y. Wang, A. Sreekumar, K.M. Buckley, H. Shi, and A. Jillella et al. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells Blood 114 2009 2733 2743
62. A.L. Reinert Orsum Bondgaard, T.T. Poulsen, H.S. Poulsen, and B.G. Skov Different expression of EZH2, BMI1 and Ki67 in low and high grade neuroendocrine tumors of the lung Cancer Biomarkers 11 2012 123 128
63. NCT00926640. A phase I study of belinostat in combination with cisplatin and etoposide in adults with small cell lung carcinoma and other advanced cancers.
64. D.A. Chan, P.D. Stutphin, P. Nguyen, S. Turcotte, E.W. Lai, and A. Banh et al. Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality Sci Trans Med 3 94 2011 94ra70
65. E. Vlashi, C. Lagadec, L. Vergnes, T. Matsutani, K. Masui, and M. Poulou et al. Metabolic state of glioma stem cells and nontumorigenic cells Proc Natl Acad Sci USA 108 2011 16062 16067
66. R.J. Gillies, I. Robey, and R.A. Gatenby Causes and consequences of increased glucose metabolism of cancers J Nucl Med 49 2008 24S 42S (Pubitemid 351948035)
67. O.E. Pardo, A. Lesay, A. Arcaro, R. Lopes, B.L. Ng, and P.H. Warne et al. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells Mol Cell Biol 23 2003 7600 7610 (Pubitemid 37271459)
68. F. Pampaloni, E.G. Reynaud, and E.H. Stelzer The third dimension bridges the gap between cell culture and live tissue Nat Rev Mol Cell Biol 8 2007 839 845 (Pubitemid 47462131)
69. C.L. Hann, V.C. Daniel, E.A. Sugar, I. Dobromilskaya, S.C. Murphy, and L. Cope et al. Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2 in small cell lung cancer Cancer Res 68 2008 2321 2328 (Pubitemid 351521806)
70. R.L. Zinn, E.E. Gardner, I. Dobromilskaya, S. Murphy, and L. Marchionni et al. Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer Mol Cancer 12 2013 16
71. C.M. Rudin, S. Durinck, J.T. Stawiski Poirier, Z. Modrusan, D.S. Shames, and E.A. Bergbower et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer Nat Genet 44 2012 1111 1116
72. C.M. Rudin, C.L. Hann, E.B. Garon, M.R. de Oliveira, P.D. Bonomi, and D.R. Camidge et al. Phase II study of single agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer Clin Cancer Res 18 2012 3163 3169
73. C.D. Salcido, A. Larochelle, B.J. Taylor, C.E. Dunbar, and L. Varticovski Molecular characterization of side population cells with cancer stem cell-like characteristics in small cell lung cancer Br J Cancer 102 2010 1636 1644
74. B. Wang, H. Yang, Y.Z. Huang, R.H. Yan, F.J. Liu, and J.N. Zhang Biologic characteristics of the side population of human small cell lung cancer cell line H446 Chin J Cancer 29 2010 254 260
75. K.S. Park, M.C. Liang, D.M. Raiser, R. Zamponi, R.R. Roach, and S.J. Curtis et al. Characterization of the cell of origin for small cell lung cancer Cell Cycle 10 2011 2806 2815
76. E. Petrova, J. Rios-Esteves, O. Ouergelli, J.F. Glickman, and M.D. Resh Inhibitors of hedgehog acyltranferase block sonic hedgehog signaling Nat Chem Biol 9 2013 247 249
77. S.D. Castillo, A. Matheu, N. Mariani, J. Carretero, F. Lopez-Rios, and R. Lovell-Badge et al. Novel transcriptional targets of the SRY-HMG box transcription factor SOX4 link its expression to the development of small cell lung cancer Cancer Res 72 2011 176 186
78. P. Wang, Q. Gao, Z. Suo, E. Munthe, S. Solberg, and L. Ma et al. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines PLoS ONE 8 3 2013 e57020 10.1371/journal.pone.0057020
79. A.F. Gazdar, B. Gao, and J.D. Minna Lung cancer cell lines: useless artifacts or invaluable tools for medical science? Lung Cancer 68 2010 309 318
80. B.P. Coe, E.H.L. Lee, B. Chi, L. Girard, J.D. Minna, and A.F. Gazdar et al. Gain of a region on 7p22.3, containing MADILI, is the most frequent event in small cell lung cancer cell lines Gene Chrom Cancer 45 2006 11 19 (Pubitemid 46930857)